Close



Dec 6, 2023 06:19AM
Nov 2, 2023 07:52AM
Nov 2, 2023 06:48AM
Sep 25, 2023 08:35AM
Sep 25, 2023 08:34AM
Aug 21, 2023 08:02AM
Aug 21, 2023 06:16AM Regeneron Pharma (REGN) PT Raised to $1,050 at Oppenheimer
Aug 3, 2023 06:33AM
Jun 28, 2023 01:57PM
May 4, 2023 06:33AM
May 4, 2023 06:30AM
Mar 23, 2023 08:20AM
Feb 3, 2023 11:38AM
Feb 3, 2023 08:33AM Apple, Amazon, Alphabet, Ford all fall in premarket
Feb 3, 2023 06:33AM
Feb 3, 2023 06:30AM
Jan 9, 2023 08:56AM
Nov 3, 2022 07:26AM
Nov 3, 2022 06:32AM
Nov 3, 2022 06:30AM
Oct 26, 2022 05:20PM Today's Most Important Downgrades
Oct 20, 2022 06:55AM
Oct 3, 2022 05:18PM
Aug 4, 2022 10:21AM
Aug 3, 2022 01:42PM
Aug 3, 2022 06:38AM
Aug 3, 2022 06:30AM
Jul 20, 2022 06:34AM Regeneron Pharma (REGN) PT Raised to $645 at Cowen
Jul 14, 2022 12:59AM
Jul 1, 2022 07:00AM
May 31, 2022 08:36AM
May 31, 2022 08:31AM
May 4, 2022 01:51PM
May 4, 2022 06:32AM
May 4, 2022 06:30AM Regeneron Reports First Quarter 2022 Financial and Operating Results
Feb 4, 2022 10:04AM
Feb 4, 2022 06:31AM
Feb 4, 2022 06:30AM
Jan 19, 2022 05:35AM
Jan 19, 2022 01:00AM
Nov 5, 2021 01:33PM
Nov 4, 2021 06:37AM Regeneron (REGN) Tops Q3 EPS by $6.15
Nov 4, 2021 06:30AM
Sep 19, 2021 06:16PM
Sep 19, 2021 11:30AM
Sep 19, 2021 11:30AM
Aug 5, 2021 06:33AM
Aug 5, 2021 06:30AM
Aug 5, 2021 06:04AM Regeneron (REGN) Phase 3 Trial of Libtayo® Stopped Early Due to Significant Improvement in Overall Survival
Aug 5, 2021 06:00AM

941,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All